ATLANTIC CANADA ENTREPRENEURS FIND THEIR BIOTECHNOLOGY NICHE AT INTERNATIONAL CONFERENCEadmin July 17, 2015
Fredericton, New Brunswick (July 17, 2015) – Twenty organizations including five Atlantic Canada biotechnology companies and four research organizations are attending the 2015 BIO World Congress on Industrial Biotechnology in Montreal, with the support of funding from ACOA and the four Atlantic provincial governments. The outgoing mission is supported through the Canada/Atlantic Provinces Agreement on International Business Development (IBDA) and coordinated by BioNB under the umbrella of the Atlantic Canada Bio-Industries Alliance.
The outgoing mission to World Congress on Industrial Biotechnology will facilitate a coordinated regional presence at one of the world’s most significant annual conferences on industrial biotechnology. “This event is a natural fit to explore opportunities with our region’s biomass and waste streams,” says Meaghan Seagrave, Executive Director of BioNB.
At World Congress, BioNB will coordinate activities around providing a concierge service to Atlantic Canadian delegates, facilitating matchmaking meetings, providing booth space for displays and business-to-business meetings. The Congress also offers the opportunity to network and form new research and business partnerships through hosted events like the Atlantic Canada Networking Breakfast and a partnered event featuring executives from multinational corporations who will talk about strategic supply chain opportunities.
“This conference is strategic in that many of the opportunities in biotechnology, life sciences and medical technologies in our region originate from industrial-based biotechnology and our natural resources, adds Seagrave.
In addition to supporting BIO World Congress, IBDA is funding an incoming bio-partnering mission for up to 26 bio based companies in Atlantic Canada. During the incoming bio-partnering missions, Atlantic Canada biosciences organizations can meet with other international companies to help with new product development, talent recruitment, investment opportunities, export opportunities and collaboration on research and development. Many of the incoming missions this year will build on successful international business development activities that have taken place over the past several years, including regional attendance at BIO World Congress on Industrial Biotechnology in Montreal, QC. BioNova is coordinating the recruitment for the incoming Atlantic biopartnering missions for the current fiscal year under the umbrella of the Atlantic Canada Bio-Industries Alliance.
The biosciences sector in Atlantic Canada is composed of over 200 companies and 30 research organizations ranging from established operations with global reach to newer startups seeking new markets and expertise. The sector includes all science- and technology-based products and services related to human health, natural resources as well as certain segments of the animal health industry. The major industry segments covered are pharmaceuticals (including vaccines), medical devices and laboratory instruments, health information technology, bioproducts, bioenergy and biofuels and natural health products.
Last year’s BIO World Congress on Industrial Biotechnology brought together delegates representing 45+ countries. Eleven Atlantic Canada companies and researchers participated in last year’s event in Philadelphia, PA. This event is an important tool for companies and researchers who are pursuing commercial and research opportunities within this sector. This event is a strategic fit for New Brunswick and the region in terms of the bioscience sector as was evidenced by the Atlantic contingent and the organizations that work with and support them.
During fiscal 2014-2015, 18 incoming life sciences missions were completed under the Atlantic biopartnering project funded by IBDA, yielding 92 export or market development activities.
Canada enjoys a low cost research and manufacturing base, ranking second in the G7 for clinical trials operation and in cost-effectiveness in the establishment and operation of manufacturing facilities.
In Canada, 44 percent of university spin-offs (firms created by universities and staff to commercialize their intellectual property) are in the biotechnology and life-sciences sector.
The IBDA is a federal/provincial agreement between the Government of Canada (ACOA, Foreign Affairs, Trade and Development Canada, and Industry Canada) and the four provincial governments in Atlantic Canada and is designed to help Atlantic Canadian businesses enter, explore and succeed in international markets. The IBDA is a key component of a pan-Atlantic effort to foster business relations, attract foreign investment and nurture technological co-operation.
Participants at 2015 BIO World Congress on Industrial Biotechnology
– Atlantic Canada Opportunities Agency
– Atlantic Council for Bioenergy Cooperative
– BioEnergy Inc.
– College Communautaire du Nouveau-Brunswick Biorefinery Technology Scale-up Centre
– Complete Senergy Systems Inc.
– Dalhousie University
– Développement Innovation Saint-Quentin Inc. (DISQ)
– National Research Council Canada
– National Research Council Canada – IRAP
– New Brunswick Department of Agriculture Aquaculture and Fisheries
– Nova Scotia Business Inc.
– Opportunities NB
– Origin Xtractions Ltd.
– PEI BioAlliance
– Semintha Nutraceuticals
– University of New Brunswick
BioNB is the trusted bioscience authority in New Brunswick for government, industry, and media, translating and communicating the business opportunities behind the science in a highly technical sector. BioNB builds and enhances new and existing businesses, supports technology transfer from public institutions and the private sector, and works to build a community and enhance collaboration among sector stakeholders.